Oxford Biomedica Solutions
Vinutha K. is a Senior Scientist II at Novartis since October 2023, bringing extensive experience in quality control and analytical development. Prior to Novartis, Vinutha held positions at Oxford Biomedica Solutions as a Senior Quality Control Analyst and Quality Control Analyst in Molecular Biology. Vinutha's career also includes roles at Homology Medicines, Inc. in Quality Control - Analytics, and Assembly Biosciences, Inc. as a Scientist-I in Analytical Development. Additional experience includes working as a Safety Specialist at PPD, Analytical Quality Control Chemist at Ascent Pharmaceuticals, Biomarker Assay Scientist at Pfizer, and Research Assistant at Tufts Medical Center. Vinutha holds a Master of Science in Pharmaceutical Sciences, Pharmacology from Northeastern University.
This person is not in any offices
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.